A Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjects

Clinical trial NCT05918614 · COMPLETED

Trial details

NCT number: NCT05918614
Sponsor: Kadmon, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immune System Disorder (Healthy Volunteer)

Start date: 2014-03-28
Primary completion: 2014-06-07
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.